Clinical Trial: PREemptive Pharmacogenomic Testing for Preventing Adverse Drug REactions

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: PREemptive Pharmacogenomic Testing for Preventing Adverse Drug REactions

Brief Summary: PREPARE is an international, prospective, multi-center, open, randomized, cross-over implementation study assessing the impact of pre-emptive pharmacogenomic testing, of a panel of actionable pharmacogenomic variants, on adverse event incidence. Additional outcomes include, healthcare expenditure, process indicators for implementation and provider adoption of pharmacogenomics.